Your organization must effectively monitor protocol adherence, manage deviations and corrective actions, and oversee vendors and partners to ensure quality standards are maintained throughout the clinical trial lifecycle. In addition, the increasing volume of data generated from multiple sources, evolving regulatory expectations, and the need for timely decision-making require robust quality management systems and risk-based oversight approaches.
DGE invites you to attend its 3rd Clinical Quality Oversight Summit – your can’t-miss forum for protecting patients, ensuring clinical data reliability, and supporting regulatory approval of new therapies. Join us September 23-24, 2027 in Philadelphia for answers to these and other essential questions!
Featured Topics and Discussions:
- Managing Data in Decentralized Trials
- Recognizing New Applications for AI and Automation
- Identifying Hidden Threat Sources in Clinical Trials
- Implementing Risk-Based Quality Management
- Building Future-Ready Change Management
*Clinical Quality Oversight
- Clinical Compliance
- Quality Investigation / Analytics
- GCP Quality Assurance
- Study Monitoring
- Adaptive Monitoring
- Medical Quality Systems
- Precision Medicine, Diagnostics, and Supplier Quality
- Quality Assurance/ Insights
- Central Monitoring/Site Monitoring
- Clinical Outsourcing / Innovation
- GXP Services
- Clinical Standards
- Clinical Monitoring
- Risk Assessment
- Quality Operations
- Clinical Quality Assurance
- Data Management and Analytics
- GCP, GVP, GLP
- Operational Delivery
- Data Monitoring
- Quality Audits and Compliance
- Risk Based Quality Management
- Risk Evaluation and Adaptive Integrated Monitoring
- Study Optimization / Operations
- Global Monitoring Strategies
- Research and Development Operations/ Quality
- Vendor Management
- Quality Assurance Auditor
